Analyst consensus rating
Korsana Biosciences Analyst Rating: Strong Buy
Direct answer
Korsana Biosciences's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $44.00.
Forecast evidence checked November 13, 2026.
Get free Korsana Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.28
- Average price target
- $44.00
- High price target
- $70.00
- Low price target
- $8.00
- Low target gap
- -74.4%
- Target upside
- +40.7%
- High target gap
- +123.8%
- Target range width
- 198.2%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Korsana Biosciences?
Korsana Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $44.00.
How far are Korsana Biosciences's low and high targets from the recorded price?
The low target implies -74.4%, while the high target implies +123.8%.
How many analysts are included in Korsana Biosciences's consensus?
The verified consensus includes 5 analysts.
How is Korsana Biosciences's target upside or downside calculated?
The average target of $44.00 is divided by the recorded price of $31.28, then one is subtracted to produce +40.7%. This does not guarantee a future return.
When was Korsana Biosciences's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.